MedPath

Tramadol

Generic Name
Tramadol
Brand Names
Conzip, Durela, Qdolo, Ralivia, Ryzolt, Seglentis, Tridural, Ultracet, Ultram, Zytram
Drug Type
Small Molecule
Chemical Formula
C16H25NO2
CAS Number
27203-92-5
Unique Ingredient Identifier
39J1LGJ30J
Background

Tramadol is a centrally acting synthetic opioid analgesic and SNRI (serotonin/norepinephrine reuptake-inhibitor) that is structurally related to codeine and morphine. Due to its good tolerability profile and multimodal mechanism of action, tramadol is generally considered a lower-risk opioid option for the treatment of moderate to severe pain. It is considered a Step 2 option on the World Health Organization's pain ladder and has about 1/10th of the potency of morphine.

Tramadol differs from other traditional opioid medications in that it doesn't just act as a μ-opioid agonist, but also affects monoamines by modulating the effects of neurotransmitters involved in the modulation of pain such as serotonin and norepinpehrine which activate descending pain inhibitory pathways. Tramadol's effects on serotonin and norepinephrine mimic the effects of other SNRI antidepressants such as duloxetine and venlafaxine.

Tramadol exists as a racemic mixture consisting of two pharmacologically active enantiomers that both contribute to its analgesic property through different mechanisms and are also themselves metabolized into active metabolites: (+)-tramadol and its primary metabolite (+)-O-desmethyl-tramadol (M1) are agonists of the μ opioid receptor while (+)-tramadol inhibits serotonin reuptake and (-)-tramadol inhibits norepinephrine reuptake. These pathways are complementary and synergistic, improving tramadol's ability to modulate the perception of and response to pain.

Tramadol has also been shown to affect a number of other pain modulators within the central nervous system as well as non-neuronal inflammatory markers and immune mediators. Due to the broad spectrum of targets involved in pain and inflammation, it's not surprising that the evidence has shown that tramadol is effective for a number of pain types including neuropathic pain, post-operative pain, lower back pain, as well as pain associated with labour, osteoarthritis, fibromyalgia, and cancer. Due to its SNRI activity, tramadol also has anxiolytic, antidepressant, and anti-shivering effects which are all frequently found as comorbidities with pain.

Similar to other opioid medications, tramadol poses a risk for development of tolerance, dependence and abuse. If used in higher doses, or with other opioids, there is a dose-related risk of overdose, respiratory depression, and death. However, unlike other opioid medications, tramadol use also carries a risk of seizure and serotonin syndrome, particularly if used with other serotonergic medications.

Indication

Tramadol is approved for the management of moderate to severe pain in adults.

Tramadol is also used off-label in the treatment of premature ejaculation.

Associated Conditions
Acute Pain, Premature Ejaculation, Severe Pain, Acute, moderate, severe Pain, Moderate Pain

The Effect of Naldemedine on Opioid-induced Bowel Dysfunction

Phase 2
Recruiting
Conditions
Opioid-Induced Bowel Dysfunction
Constipation
Interventions
First Posted Date
2024-03-27
Last Posted Date
2024-03-28
Lead Sponsor
Asbjørn Mohr Drewes
Target Recruit Count
20
Registration Number
NCT06334198
Locations
🇩🇰

Aalborg University Hospital, Aalborg, Denmark

Adding Dexmedetomidine or Tramadol to Paracetamol- An Effort to Attenuate Catheter Related Bladder Discomfort

Phase 3
Recruiting
Conditions
Percutaneous Nephrolithotripsy (PCNL)
Interventions
First Posted Date
2024-02-23
Last Posted Date
2024-07-31
Lead Sponsor
Al-Azhar University
Target Recruit Count
60
Registration Number
NCT06274333
Locations
🇪🇬

Neveen Kohaf, Cairo, Egypt

Tapentadol vs Tramadol in Total Knee Arthroplasty

Phase 4
Recruiting
Conditions
Total Knee Replacement
Post-operative Pain
Chronic Pain
Interventions
First Posted Date
2024-02-21
Last Posted Date
2024-05-14
Lead Sponsor
University of Thessaly
Target Recruit Count
96
Registration Number
NCT06269770
Locations
🇬🇷

University Hospital Of Larissa, Larissa, Thessaly, Greece

Efficacy and Safety of DIT112 in the Treatment of Moderate to Severe Pain After Dental Surgery for the Extraction of Impacted Third Molars

Phase 3
Not yet recruiting
Conditions
Moderate Pain
Severe Pain
Interventions
First Posted Date
2024-02-01
Last Posted Date
2024-02-20
Lead Sponsor
EMS
Target Recruit Count
252
Registration Number
NCT06237231

5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Randomized Clinical Trial

Phase 2
Active, not recruiting
Conditions
Intra-abdominal Cancer
Interventions
First Posted Date
2024-01-31
Last Posted Date
2025-04-11
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
170
Registration Number
NCT06232577
Locations
🇺🇸

MD Anderson Cancer Center, Houston, Texas, United States

Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Bunionectomy

Phase 3
Completed
Conditions
Acute Pain
Post Operative Pain
Pain
Interventions
First Posted Date
2024-01-22
Last Posted Date
2025-05-04
Lead Sponsor
Viatris Specialty LLC
Target Recruit Count
408
Registration Number
NCT06215820
Locations
🇺🇸

Investigator site 105, San Antonio, Texas, United States

🇺🇸

Investigator site 101, Salt Lake City, Utah, United States

🇺🇸

Investigator site 112, Miami, Florida, United States

and more 12 locations

Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Herniorrhaphy

Phase 3
Completed
Conditions
Acute Pain
Post Operative Pain
Pain
Interventions
First Posted Date
2024-01-22
Last Posted Date
2025-05-04
Lead Sponsor
Viatris Specialty LLC
Target Recruit Count
579
Registration Number
NCT06215859
Locations
🇺🇸

Investigator site 213, Phoenix, Arizona, United States

🇺🇸

Investigator site 212, Bellaire, Texas, United States

🇺🇸

Investigator site 204, Houston, Texas, United States

and more 15 locations

Comparison of Tramadol, Pethidine and Morphine in the Treatment of Pain After Thoracic Surgery

Phase 4
Not yet recruiting
Conditions
Analgesia
Thoracic Diseases
Interventions
First Posted Date
2023-12-15
Last Posted Date
2023-12-15
Lead Sponsor
Baskent University
Target Recruit Count
45
Registration Number
NCT06172920
Locations
🇹🇷

Baskent University Ankara Hospital, Ankara, Turkey

Tramadol and Tramadol Plus Ketamine for Shivering Prevention After Spinal Anesthesia in Lower Segment Caeserian Section

Phase 4
Recruiting
Conditions
Shivering
Interventions
First Posted Date
2023-11-18
Last Posted Date
2023-11-18
Lead Sponsor
Ziauddin University
Target Recruit Count
190
Registration Number
NCT06134895
Locations
🇵🇰

Muhammad Arif, Karachi, Sindh, Pakistan

Preemptive Oral Gabapentin and Tramadol on Postoperative Pain After Knee Arthroscopy

Not Applicable
Completed
Conditions
Gabapentin
Tramadol
Postoperative Pain
Knee Arthroscopy
Spinal Anesthesia
Interventions
First Posted Date
2023-11-01
Last Posted Date
2024-10-02
Lead Sponsor
Tanta University
Target Recruit Count
50
Registration Number
NCT06112223
Locations
🇪🇬

Tanta University, Tanta, El-Gharbia, Egypt

© Copyright 2025. All Rights Reserved by MedPath